Delivery Order SPE2DB22D1106-SPE2DB24FFLV5

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,166.99 contract is for the delivery of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a period of performance through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a ceiling value of $1,983.94 and a performance period extending through May 13, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,800.64, is for the supply of ZORYVE 0.3% FOAM 60GM medical products. The contract is a Firm Fixed Price agreement with an ultimate completion date of November 7, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a firm fixed price ceiling value of $1,392.55. The period of performance extends to May 16, 2025. This contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,384.83, is for the supply of the pharmaceutical product ZORYVE 0.3% FOAM 60GM. The contract has a firm fixed price pricing type and a period of performance through February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a medical product. The contract has a firm fixed price, with a ceiling value of $1,231.98, and an ultimate completion date of May 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for $1,709.93 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for "ZORYVE 0.3% FOAM 60GM" with a completion date of June 11, 2025. The contract has a firm fixed-price pricing type and is not a set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZORYVE 0.3% Foam, a prescription medication, with a ceiling value of $1,586.14 and a period of performance through May 19, 2025. The contract is not set aside and was awarded on an open competition basis. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a $15,023.02 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 60 gram tubes of Zoryve 0.3% foam, a prescription topical medication, with a completion date of June 16, 2025. This award is associated with Amerisourcebergen's large $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,268.55 firm fixed price delivery order is for the supply of 60 gram tubes of Zoryve 0.3% foam, a pharmaceutical product. The contract has a completion date of June 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFLV5
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp in the amount of $12,485.88 for the supply of ZORYVE 0.3% FOAM 60GM. This contract has a period of performance through September 10, 2024 and is not set aside for any special designation. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription dermatological products through an existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which can be valued up to $999,999,999 through December 2025 for a wide range of medical commodities to support military healthcare programs.

Generated 12/9/24, 1:55 PM